VEGFA and metastatic carcinoma: While ischemic events did not occur thereafter, the patient died due to metastatic carcinoma progression.<h4>Conclusions</h4>This case suggests that anti-vascular endothelial growth factor might contribute to early stent thrombosis, despite triple antithrombotic therapy.